Trial of Dexamethasone for Chronic Subdural Hematoma

In a trial that compared a 2-week course of dexamethasone with placebo in patients with a chronic subdural hematoma, a favorable outcome on the modified Rankin scale at 6 months was more common in the placebo group than in the dexamethasone group, but repeat surgery to evacuate a hematoma was perfor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2020-12, Vol.383 (27), p.2616-2627
Hauptverfasser: Hutchinson, Peter J, Edlmann, Ellie, Bulters, Diederik, Zolnourian, Ardalan, Holton, Patrick, Suttner, Nigel, Agyemang, Kevin, Thomson, Simon, Anderson, Ian A, Al-Tamimi, Yahia Z, Henderson, Duncan, Whitfield, Peter C, Gherle, Monica, Brennan, Paul M, Allison, Annabel, Thelin, Eric P, Tarantino, Silvia, Pantaleo, Beatrice, Caldwell, Karen, Davis-Wilkie, Carol, Mee, Harry, Warburton, Elizabeth A, Barton, Garry, Chari, Aswin, Marcus, Hani J, King, Andrew T, Belli, Antonio, Myint, Phyo K, Wilkinson, Ian, Santarius, Thomas, Turner, Carole, Bond, Simon, Kolias, Angelos G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In a trial that compared a 2-week course of dexamethasone with placebo in patients with a chronic subdural hematoma, a favorable outcome on the modified Rankin scale at 6 months was more common in the placebo group than in the dexamethasone group, but repeat surgery to evacuate a hematoma was performed more frequently in the placebo group.
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa2020473